JulietEWolfordMD

Obstetrics & Gynecology • Cincinnati, OH

Gynecologic Oncology

Gynecologic Oncologist

Join to view full profile

Dr. Wolford is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Wolford's full profile

Already have an account?

Office
234 Goodman Drive
Cincinnati, OH 45219
Phone+1 513-558-8448
Is this information wrong?

Education & Training

University of California (Irvine)Fellowship, Gynecologic Oncology, 2016 - 2020
University of California (Irvine)Residency, Obstetrics and Gynecology, 2012 - 2016
Marshall University Joan C. Edwards School of MedicineClass of 2012

Certifications & Licensure

OH State Medical License 2020 - 2024
CA State Medical License 2014 - 2021
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Publications & Presentations

PubMed

Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma.
Kathleen Lundeberg, Juliet Wolford, Thomas Reid> ;Gynecologic Oncology Reports. 2024 Jun 1
3 citations
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.
Juliet E Wolford, Erin Ferrigni, Daniel Margul, Thomas J Herzog> ;Current Oncology Reports. 2022 Jul 1
1 citations
Surgical Management of Gynecologic Cancers.
Kiran Clair, Juliet Wolford, Jason A. Zell, Robert E. Bristow> ;Surgical Oncology Clinics of North America. 2021 Jan 1
20 citations
Cost-effectiveness of niraparib, rucaparib, and olaparib for treatment of platinum-resistant, recurrent ovarian carcinoma.
Juliet E Wolford, Jiaru Bai, Kathleen N. Moore, Rebecca Kristeleit, Bradley J. Monk, Krishnansu S. Tewari> ;Gynecologic Oncology. 2020 May 1
13 citations
A profile on the FoundationFocus CDxBRCA tests
Lindsey Ford, Juliet E Wolford, Sandra Brown, Leslie M. Randall> ;Expert Review of Molecular Diagnostics. 2020 Feb 6
9 citations
Endometrial cancer in the morbidly obese: a review
Marisa C Liu, Austin B Gardner, Juliet E Wolford, Krishnansu S. Tewari> ;Current Opinion in Obstetrics & Gynecology. 2020 Feb 1
4 citations
Fertility preserving treatment for gynecologic malignancies: a review of recent literature
Katherine Coakley, Juliet E Wolford, Krishnansu S. Tewari> ;Current Opinion in Obstetrics & Gynecology. 2020 Feb 1
19 citations
Rational design for cervical cancer therapeutics: cellular and non-cellular based strategies on the horizon for recurrent, metastatic or refractory cervical cancer.
Juliet E Wolford, Krishnansu S. Tewari> ;Expert Opinion on Drug Discovery. 2018 Feb 26
5 citations
Primary low-grade endometrial stromal sarcoma of the omentum.
Kiran Clair, Juliet E Wolford, Sonia Veran-Taguibao, Grace Kim, Ramez N. Eskander> ;Gynecologic Oncology Reports. 2017 Aug 1
4 citations
Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical Oncology.
Juliet E Wolford, Krishnansu S. Tewari> ;Journal of Gynecologic Oncology. 2017 Mar 17
3 citations
US FDA oncology drug approvals in 2014
Juliet E Wolford, Krishnansu S. Tewari> ;Future Oncology. 2015 May 22
Urticarial Vasculitis in a Teenage Girl.
Aaron McGuffin, Amy Vaughan, Juliet E Wolford> ;Journal of Investigative Medicine High Impact Case Reports. 2013 Apr 12
Join now to see all

Journal Articles

Cost-Effectiveness of Niraparib, Rucaparib, and Olaparib for Treatment of Platinum-Resistant, Recurrent Ovarian Carcinoma
Juliet Wolford, MD, Gynecologic Oncology

Lectures

SOLO1 versus SOLO2: Cost-effectiveness of olaparib as maintenance therapy for newly diagnosed and platinum-sensitive recurrent ovarian carcinoma among women with germl...
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019